Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.

Severe alpha-1-antitrypsin deficiency is the only proven genetic risk factor for chronic obstructive pulmonary disease (COPD). We have assembled a cohort of 44 probands with severe, early-onset COPD, who do not have severe alpha-1-antitrypsin deficiency. A surprisingly high prevalence of females (79.6%) was found. Assessment of the risk to relatives of these early-onset COPD probands for airflow obstruction and chronic bronchitis was performed to determine whether significant familial aggregation for COPD, independent of alpha-1-antitrypsin deficiency, could be demonstrated. First- degree relatives of early-onset COPD probands had significantly lower FEV1 and FEV1/FVC values than control subjects (p < 0.01), despite similar pack-years of smoking. Reduced spirometric values in first-degree relatives of early-onset COPD probands were found only in current or ex-cigarette smokers. The mean FEV1 in current or ex-smoking first-degree relatives was 76.1 +/- 20.9% predicted compared to 89.2 +/- 14.4% predicted in current or ex-smoking control subjects (p < 0.01); in lifelong nonsmokers, the mean FEV1 was 93.4% predicted for both control subjects and first-degree relatives of early-onset COPD probands. Generalized estimating equations, adjusting for age and pack-years of smoking, demonstrated increased odds of reduced FEV1 and chronic bronchitis in current or ex-smoking first-degree relatives of early-onset COPD probands. Using a new method to estimate relative risk from relative odds, we estimate that the relative risks for FEV1 below 60%, FEV1 below 80%, and chronic bronchitis are each approximately three in current or ex-smoking first-degree relatives of early-onset COPD probands. The increased risk to relatives of early-onset COPD probands for reduced FEV1 and chronic bronchitis, limited to current or ex-smokers, suggests genetic risk factor(s) for COPD that are expressed in response to cigarette smoking.

[1]  T. Novotny,et al.  The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[2]  W. C. Ball,et al.  Risk factors in chronic obstructive pulmonary disease (COPD). , 1977, American Journal of Epidemiology.

[3]  J. A. Martin,et al.  ADVANCE REPORT OF FINAL NATALITY STATISTIC, 1992 , 1994 .

[4]  R. K. Larson,et al.  Genetic and environmental determinants of chronic obstructive pulmonary disease. , 1970, Annals of internal medicine.

[5]  R M Gardner,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[6]  B. Hsi,et al.  Ventilatory functions of normal children and young adults--Mexican-American, white, and black. I. Spirometry. , 1979, The Journal of pediatrics.

[7]  F. Speizer,et al.  Household aggregation of pulmonary function and chronic bronchitis. , 2015, The American review of respiratory disease.

[8]  N. Risch,et al.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. , 1989, American journal of human genetics.

[9]  E. Silverman,et al.  Risk factors for the development of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.

[10]  D. Postma,et al.  Prognosis in severe chronic obstructive pulmonary disease. , 1979, The American review of respiratory disease.

[11]  M. Feinleib,et al.  Trends in COPD morbidity and mortality in the United States. , 1989, The American review of respiratory disease.

[12]  E. Campbell,et al.  Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. , 1996, Journal of immunology.

[13]  M. Higgins,et al.  Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. , 1975, Journal of chronic diseases.

[14]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. , 1990, Human heredity.

[15]  Pierce Ja,et al.  Improved identification of antitrypsin phenotypes through isoelectric focusing with dithioerythritol. , 1979 .

[16]  H. Magnussen,et al.  Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. , 1994, The European respiratory journal.

[17]  E. Silverman,et al.  Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. , 1989, The American review of respiratory disease.

[18]  T. Beaty,et al.  Robust inference for variance components models in families ascertained through probands: II. Analysis of spirometric measures , 1987, Genetic epidemiology.

[19]  S L Zeger,et al.  Regression analysis for correlated data. , 1993, Annual review of public health.

[20]  C. Boudier,et al.  The functional activity of α1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers , 1983 .

[21]  N. Zamel,et al.  Pulmonary function in identical twins: comparison of nonsmokers and smokers. , 2015, The American review of respiratory disease.

[22]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[23]  D. Dockery,et al.  Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. , 1985, The American review of respiratory disease.

[24]  E. Silverman,et al.  A family study of the variability of pulmonary function in α1-antitrypsin deficiency: Quantitative phenotypes , 1990 .

[25]  F. Speizer,et al.  Genetic and environmental determinants of level of pulmonary function. , 1984, American journal of epidemiology.

[26]  S. Redline,et al.  Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. , 1989, American journal of epidemiology.

[27]  V. Sheffield,et al.  Identification of a Gene That Causes Primary Open Angle Glaucoma , 1997, Science.

[28]  N. Müller,et al.  Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients. , 1994, AJR. American journal of roentgenology.

[29]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. , 1989, Annals of internal medicine.

[30]  N. Risch.  Linkage strategies for genetically complex traits. II. The power of affected relative pairs. , 1990, American journal of human genetics.

[31]  K. Offord,et al.  Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. , 1977, The American journal of medicine.

[32]  J. Powers,et al.  Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. , 1977, Methods in enzymology.

[33]  D. O’Donnell,et al.  Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. , 1992, Chest.

[34]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[35]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.

[36]  A. Kok-Jensen,et al.  Prognosis in severe chronic obstructive pulmonary disease. , 2009, Acta medica Scandinavica.

[37]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[38]  R. Glenny,et al.  Panlobular emphysema in young intravenous Ritalin abusers. , 1991, The American review of respiratory disease.

[39]  C. Larsson.  Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. , 2009, Acta medica Scandinavica.